Thomas Waerner
Boehringer Ingelheim (Germany)(DE)Boehringer Ingelheim (Australia)(AU)
Publications by Year
Research Areas
Protein purification and stability, Viral Infectious Diseases and Gene Expression in Insects, Biosimilars and Bioanalytical Methods, Cancer Cells and Metastasis, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Expression profiling of epithelial plasticity in tumor progression(2003)299 cited
- → A crucial function of PDGF in TGF-β-mediated cancer progression of hepatocytes(2006)238 cited
- → ILEI: A cytokine essential for EMT, tumor formation, and late events in metastasis in epithelial cells(2006)183 cited
- → “High‐risk” host cell proteins (HCPs): A multi‐company collaborative view(2021)147 cited
- → Experience with host cell protein impurities in biopharmaceuticals(2018)109 cited
- Human RERE is localized to nuclear promyelocytic leukemia oncogenic domains and enhances apoptosis.(2001)
- → Cellular repressor of E1A-stimulated genes is a bona fide lysosomal protein which undergoes proteolytic maturation during its biosynthesis(2008)33 cited
- → Mass spectrometric evaluation of upstream and downstream process influences on host cell protein patterns in biopharmaceutical products(2019)22 cited
- → The role of laboratory medicine in healthcare: quality requirements of immunoassays, standardisation and data management in prospective medicine(2010)16 cited
- → Polysorbates degrading enzymes in biotherapeutics – a current status and future perspectives(2025)12 cited